Skip to main content
爱舍伦 logo

爱舍伦 — Investor Relations & Filings

Ticker · 920050 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 30 across all filing types
Latest filing 2026-03-03 Declaration of Voting R…
Country CN China
Listing Beijing Stock Exchange 920050

About 爱舍伦

http://www.excellentmedical.cn/

Ascen Medical specializes in the development, manufacturing, and distribution of medical consumables and equipment, with a primary focus on respiratory care, anesthesia, and emergency medicine. The company's product portfolio includes a wide range of airway management solutions such as laryngeal mask airways, endotracheal tubes, breathing circuits, and resuscitation bags. Ascen Medical emphasizes clinical safety and efficiency, adhering to international quality management standards to ensure product reliability. By integrating advanced manufacturing technologies with clinical insights, the company provides essential tools for healthcare professionals in critical care and surgical environments. Its commitment to innovation and quality has established it as a provider of medical solutions for global healthcare markets.

Recent filings

Filing Released Lang Actions
2026年第一次临时股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a formal announcement of the resolutions passed at the 2026 first extraordinary general meeting of shareholders of Jiangsu Aisheren Medical Technology Group Co., Ltd. It details the meeting date, attendance, voting results, and legal opinions confirming the validity of the meeting and resolutions. The content focuses on the declaration of voting results for shareholder decisions, specifically about changes in registered capital, company type, and amendments to the articles of association. There is no financial data or report content, only the official voting outcomes and legal validation. Therefore, this document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is short and it is not a report publication announcement or regulatory filing. Confidence is high due to clear voting results and legal opinion sections.
2026-03-03 Chinese
关于对全资孙公司增资的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding an increase in capital investment by a wholly-owned subsidiary of the company. It details the investment amount, purpose, decision-making process, and impact on the company. There are no financial statements or comprehensive financial data presented, nor is this a full report. The document is relatively short (2012 characters) and serves as a formal disclosure of a capital increase transaction. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes.
2026-02-25 Chinese
2025年年度业绩快报公告
Earnings Release Classification · 95% confidence The document is titled as a "2025 Annual Performance Express Announcement" and contains preliminary financial data for the year 2025, including revenue, profit, net assets, and other key financial metrics. It explicitly states that the data is preliminary, unaudited, and subject to final confirmation in the formal 2025 Annual Report. The document is relatively short (1800 characters) and serves as a quick earnings update rather than a full comprehensive report. It also includes a risk warning about the preliminary nature of the data. This matches the characteristics of an Earnings Release (ER), which is an initial announcement of quarterly or annual financial results with key highlights only, not the full annual report. Therefore, the correct classification is Earnings Release (ER). FY 2025
2026-02-25 Chinese
关于对外投资进展暨境外孙公司增资完成并取得注册登记证的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the progress of an external investment and the completion of capital increase and registration of an overseas subsidiary. It includes details about the registration certificate and related corporate actions but does not contain financial statements or detailed financial performance data. The document is relatively short (842 characters) and serves as a formal notification of corporate activity rather than a full report. Therefore, it fits best under the category of a general regulatory announcement about corporate matters, which corresponds to Regulatory Filings (RNS).
2026-02-23 Chinese
关于召开2026年第一次临时股东会通知公告（提供网络投票）
AGM Information Classification · 95% confidence The document is a notice for convening the 2026 first extraordinary general meeting of shareholders (临时股东会通知公告) of 江苏爱舍伦医疗科技集团股份有限公司. It details the meeting date, voting methods (including online voting), agenda items (such as changes to registered capital and company type, and amendments to the articles of association), registration procedures, and other meeting logistics. There is no financial data, earnings information, or audit content. The document is an announcement about the meeting itself, not the results or minutes of the meeting. It is also not a proxy solicitation or voting results announcement. Given the content and length (2821 characters), it is a formal meeting notice. Therefore, the appropriate classification is AGM Information (AGM-R).
2026-02-09 Chinese
东吴证券股份有限公司关于江苏爱舍伦医疗科技集团股份有限公司调整募集资金投资项目拟投入募集资金金额的核查意见
Audit Report / Information Classification · 95% confidence The document is a verification opinion from the sponsor (东吴证券股份有限公司) regarding the adjustment of the amount of raised funds to be invested in a project by 江苏爱舍伦医疗科技集团股份有限公司. It references regulatory approvals, fundraising details, and board resolutions approving the adjustment. The document is focused on the verification and compliance of fundraising use and adjustments, not a full financial report or earnings release. It is a formal verification or audit-type opinion related to fundraising and compliance, which fits the category of an Audit Report / Information (AR). The document length is about 2557 characters, which is too long for a simple announcement but does not contain full financial statements or management discussion, so it is not an Annual Report or Interim Report. It is not a regulatory filing or announcement of a report publication. Therefore, the best classification is AR (Audit Report / Information). Q1 2026
2026-02-09 Chinese

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.